What a fantastic week at DIA Europe 2025! Back in Basel, it was great to meet so many of you. Special thanks for the organisers for such a smooth event. The main topic of the week won't be a surprise to anyone - AI! Our product manager Luisa Burggraf delivered a fantastic presentation about how our CARA AI enables chat with data, document comparison and document generation. Contact us to learn more! #CARALifeSciencesPlatform #AI #documentcomparison #RIM #Quality #Clinical
Generis
Software Development
Enterprise Cloud Platform for Data, Business Process and Content Management
About us
Generis is a developer of world-class data, content and business process management for regulated industries globally including life sciences, financial services, government, and energy.
- Website
-
http://www.generiscorp.com
External link for Generis
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 1997
- Specialties
- CARA, CMS, Software, Life Science, Finance, Government, Regulatory, Compliance, Energy, Media, QMS, RIM, Data Management, IDMP, Safety, Clinical, eTMF, CTMS, Quality Management, Labeling, Financial Services, Digital Transformation, and Business Process Management
Locations
Employees at Generis
Updates
-
Meet Barry a pharmaceutical product navigating the full drug lifecycle in the CARA Life Sciences Platform. From discovery and clinical trials to regulatory submissions, safety monitoring, and post-marketing updates, every stage is seamlessly connected. No silos, no duplicate work just streamlined, compliant processes with full traceability. 🔹Reduce inefficiencies 🔹Ensure compliance 🔹Accelerate time to market See Barry’s journey in our infographic. https://lnkd.in/eXTWisSs #CARALifeSciences #LifeSciences #Pharma #DrugDevelopment #RegulatoryCompliance #DigitalTransformation
-
Only 1 week to go! Join us at #DIAEurope2025 and meet our team at booth c10. Catch our Senior Product Manager, Luisa Burggraf, at the Innovation Hub on March 19th at 4:20 PM. #DIA #LifeSciences #AI #Regulatory #Data
-
-
Are you attending Big Data & AI World London? Our representative Joe Hilton is excited to make some new connections.
🚀 Exciting news! Tomorrow, I'll be attending Big Data & AI World London event – one of the leading events in the data industry. It’s a great opportunity to connect with experts, explore the latest trends, and learn from top professionals in big data, AI, and analytics. If you're also attending, I’d love to catch up! Feel free to reach out, and let's arrange a time to grab a coffee and chat about the latest in the world of data. It’s always great to connect and share insights. Looking forward to seeing some of you there! ☕👋 https://lnkd.in/er7km2UA #BigDataWorld #Data #AI #Analytics #Networking #CoffeeCatchUp
-
Managing a rapidly growing portfolio of products presents many challenges. Cheplapharm needed a solution that could streamline and standardise their regulatory processes while enabling seamless collaboration. Read our case study to see how Cheplapharm unified their processes with CARA: https://lnkd.in/eQayQiAH #casestudy #lifesciences #RIM #regulatoryoperations #digitaltransformation
-
We are thrilled to be part of #DIAEurope2025 in Basel! Visit our team at booth C10 to see the latest innovations on the CARA Life Sciences Platform. Don’t miss our Product Manager Luisa Burggraf’s presentation "Chat With Your Data: Improve and Simplify Processes with GenAI" in the Innovation Hub on the 19th at 16:20! See you at DIA Europe! 🌐🤝 Click here to learn more:https://lnkd.in/eTRYjzCY #Innovation #Collaboration #Exhibition #LifeSciences
-
AI is reshaping regulatory compliance, operational workflows, and data management in life sciences. But despite its potential, adoption remains slow. We spoke with Peter Smedegaard Andersen, Partner at DAQUMA, about the challenges slowing AI adoption. Companies aren’t questioning AI’s capabilities, their key considerations are: 💡 Where is AI already delivering tangible value in Life Sciences? 💡 What’s the biggest barrier to AI implementation in their organisation? 🔹 Security & Compliance – Can AI-generated outputs be trusted in highly regulated environments? 🔹 Proving ROI – How do we measure financial impact when success depends on adoption rates and trust? 🔹 Integration Challenges – Most AI models aren’t designed for life sciences, making seamless implementation difficult. 🔹 Other (Drop your thoughts in the comments!) Read the full interview for expert insights on tackling AI adoption challenges: https://lnkd.in/e8zhrbuV #AI #LLMs #CARA #DAQUMA #Compliance #Integrations
-
-
Our partner fme US, LLC can help companies to run a thorough data assessment and guide them through the migration the the CARA Life Sciences Platform. Read their article to learn more : https://lnkd.in/dC_xqg_x #partnership #migration #datamanagement
The Generis CARA Platform is a versatile, low-code foundational content and data management platform designed to solve the complex needs of industries such as pharmaceuticals, biotech, medical devices, and other highly regulated sectors–if your data is organized to take advantage of it. Conducting a thorough data assessment of your data, metadata and documents early on helps identify gaps and areas for improvement, ensuring that all your migrated data and documents are accurate, organized and relevant. Read the article below to learn how fme’s proven methodologies minimize errors during migrations so you get the full value of your investment in the CARA platform. #migration #Generis #CARAplatform #DocumentManagement https://lnkd.in/gVUGyQRq
-
-
Why are companies choosing the CARA Platform as the cornerstone of their IT landscape? Legacy ECM systems can’t keep up with modern business needs, leading to costly inefficiencies, compliance risks, and frustrated users. So, what makes the CARA Platform different? - One platform for managing content, data & processes - AI functionality built-it - Security and compliance specific to regulated industries - Cost-effective scalability Watch now to see why global leaders are making the switch: https://lnkd.in/e9qqxAHF #ContentServices #DigitalTransformation #CARAPlatform #Generis #AI #Automation
Enterprise Content Services on the CARA Platform
https://www.youtube.com/
-
"It's not very good, but it works for now." - This is something we've heard from many companies who are still using legacy systems to manage their content. Sure, their employees waste time looking through different systems for information and risk non-compliance with manual processes, but without a solid business case they face resistance from stakeholders to get the budget for a new system and migration project. At Generis, we can help you to build a strong business case and guide you through the migration process to reduce the disruption to your teams during the project. Stop compromising with sub-standard software, and embrace AI-enabled digital transformation with the CARA Platform. #contentmanagement #AI #digitaltransformation #CARAPlatform
This content isn’t available here
Access this content and more in the LinkedIn app